Ewa Wybieralska

Ewa Wybieralska is a seasoned professional in clinical biomarker operations with extensive experience in the biotech and pharmaceutical industries. Currently serving as Senior Manager, Clinical Biomarker Operations at QurAlis since March 2023, Ewa has previously held significant positions at Sumitomo Pharma Oncology and Boston Biomedical, Inc., where responsibilities included establishing biomarker strategies and coordinating clinical sample testing. Ewa's academic background includes a Ph.D. in Biology, with a focus on molecular biology, from Jagiellonian University, complemented by a rich research history at prestigious institutions such as Brigham and Women's Hospital and participation in multidisciplinary projects at Harvard/MIT.